Bora CDMO Bora CDMO

X

Find Radio Compass News for Verapamil Hydrochloride

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
88
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET, EXTENDED RELEASE;ORAL - 120MG
  • TABLET, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET, EXTENDED RELEASE;ORAL - 240MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 120MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 180MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 240MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 360MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 100MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 200MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 300MG

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216471

FDA
23 Apr 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-26-2023-60580.pdf

FDA
26 Apr 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214653

FDA
15 Jun 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215829

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214361

FDA
20 Oct 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214215

FDA
20 Oct 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212965

FDA
09 Jul 2020

http://www.pharmabiz.com/NewsDetails.aspx?aid=122008&sid=2

PHARMABIZ
26 Mar 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211370

FDA
31 Dec 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210994

FDA
21 Jul 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211035

FDA
22 Jun 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206173

FDA
09 May 2017

http://www.pharma-excipients.ch/2016/03/02/design-and-evaluation-of-verapamil-hydrochloride-controlled-release-hydrogel-based-matrix-tablets/

PHARMA-EXCIPIENTS
01 Mar 2016

http://www.pharma-excipients.ch/2016/02/17/the-effect-of-powder-blend-on-drug-release-mechanisms-of-hydrophobic-starch-stearate-matrix-tablets/

PHARMA-EXCIPIENTS
16 Feb 2016

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53499r-eng.php

HEALTHY CANADIANS
19 May 2015

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52887r-eng.php

HEALTHY CANADIANS
13 Apr 2015

http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2023664

Press Release ALKERMES
10 Mar 2015

http://www.glenmarkpharma.com/GLN_NWS/PDF/Glenmark_announces_approval_and_launch_of_Trandolapril_and_Verapamil_Hydrochloride_HCl_Extended_Release_Tablets_in_the_US.pdf

Press Release Glenmark
26 Feb 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY